The U.S. Food and Drug Administration has granted Fast Track Designation to a new drug combination for metastatic colorectal cancer, following encouraging results from a clinical trial led in part...

For more than 35 years, University of Oklahoma Health Campus researchers have played a key role in the Strong Heart Study, a landmark project that has uncovered critical insights into...